Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nebius shares were heavily sold in an AI rotation, with an analyst proposing a buy at $8.50, stop $6.25, 45-day target $14.00.
  • Analyst cites intact recurring revenue and enterprise adoption as the basis for the tactical Nebius trade.
  • Nvidia CEO Jensen Huang is expected to attend the White House state dinner for Xi on Sept 24.
  • Huang's attendance places a U.S. AI executive at a high-profile U.S.-China diplomatic event.
  • The dinner signals that U.S.-China talks will include economic and technology issues, including AI.
  • Nvidia's participation could influence AI sector sentiment and expectations around cross-border tech policy.

Latest Articles

Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models
Aug 6, 2026
Maya Rios
Press Releases

Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models

Propanc Biopharma announced highly encouraging preclinical data for its lead candidate PRP in treating pancreatic ductal adenocarcinoma, showing over 90% tumor growth inhibition, reduced metastasis, and more than 2.5-fold increase in median survival in animal models. The data supports PRP’s novel mechanism targeting cancer stem cells and tumor micr…

PPCB
Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder
Aug 6, 2026
Marcus Reed
Press Releases

Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

Vistagen announced positive topline results from its Phase 2 repeat dose study evaluating fasedienol nasal spray for acute treatment of social anxiety disorder (SAD). The study showed favorable safety and tolerability, with numerical improvements over placebo on primary and secondary efficacy endpoints, particularly in patients with very severe SAD…

VTGN
The Metals Company Announces Second Quarter 2026 Corporate Update Conference Call for Thursday, August 13, 2026
Aug 6, 2026
Maya Rios
Press Releases

The Metals Company Announces Second Quarter 2026 Corporate Update Conference Call for Thursday, August 13, 2026

The Metals Company Inc. announced it will host a conference call on August 13, 2026, to discuss its second quarter 2026 financial results and recent corporate developments. The company is involved in developing critical metals from seafloor polymetallic nodules, focusing on supplying metals with lower environmental impact and advancing recycling ef…

TMC
Arteris Appoints Saurabh Sinha as Chief Financial Officer
Aug 6, 2026
Jordan Park
Press Releases

Arteris Appoints Saurabh Sinha as Chief Financial Officer

Arteris, a semiconductor technology company specialized in network-on-chip interconnect IP, has appointed Saurabh Sinha as its new Chief Financial Officer effective September 8, 2026. Sinha replaces Nick Hawkins, who is retiring after seven years and will assist with the transition in an advisory capacity. Sinha brings extensive financial leadershi…

AIP
Stran & Company Schedules Second Quarter 2026 Financial Results and Business Update Conference Call
Aug 6, 2026
Sofia Navarro
Press Releases

Stran & Company Schedules Second Quarter 2026 Financial Results and Business Update Conference Call

Stran & Company, a leading outsourced marketing solutions provider specializing in promotional products and loyalty incentive programs, announced a conference call on August 12, 2026, to discuss its second quarter 2026 financial results and corporate developments. The call will feature insights into the company’s business progress and strategic ini…

SWAG
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Aug 6, 2026
Hana Yamamoto
Press Releases

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen Inc., a Nasdaq-listed online marketplace connecting scientists with biospecimens for medical research, announced the pricing of a $5 million public offering of common stock and pre-funded warrants at $1.30 per share. Proceeds will be used to repay liabilities, possibly acquire assets, invest in business and marketing activities, and for w…

ISPC
RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors
Aug 6, 2026
Ajmal Hussain
Press Releases

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

RenovoRx announced the first commercial clinical use of its FDA-cleared drug-delivery device, RenovoCath, for treating a sarcoma patient, marking a significant expansion of the device's application beyond pancreatic cancer to other solid tumors. Treatment at CARTI Cancer Center involves localized chemotherapy delivery near the tumor, potentially re…

RNXT
Cloudastructure Wins Full Guard Replacement Across Five-Building Southern California Office Portfolio for One of the World's Largest Commercial Real Estate Firms
Aug 6, 2026
Priya Menon
Press Releases

Cloudastructure Wins Full Guard Replacement Across Five-Building Southern California Office Portfolio for One of the World's Largest Commercial Real Estate Firms

Cloudastructure, Inc. announced the deployment of its AI Surveillance and Remote Guarding platform to fully replace onsite security guards across a five-building commercial office portfolio in Southern California. The implementation will establish new camera surveillance infrastructure, expanding Cloudastructure's presence in commercial real estate…

CSAI
Onfolio Holdings Announces 1-For-50 Reverse Stock Split To Regain Nasdaq Compliance; Reducing Float To Approximately 850,000 Shares
Aug 6, 2026
Priya Menon
Press Releases

Onfolio Holdings Announces 1-For-50 Reverse Stock Split To Regain Nasdaq Compliance; Reducing Float To Approximately 850,000 Shares

Onfolio Holdings, Inc. is implementing a 1-for-50 reverse stock split effective August 10, 2026, to increase its stock price above $1.00 and regain compliance with Nasdaq listing rules. This corporate action will reduce the outstanding shares from approximately 42 million to 850,000 shares. The company's ticker will remain ONFO, and trading will co…

ONFO
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series
Aug 6, 2026
Hana Yamamoto
Press Releases

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Onconetix, a Nasdaq-listed biotechnology firm, is set to acquire Realbotix LLC, a company specializing in AI-powered humanoid robots. Realbotix recently secured an agreement to have one of its humanoid robots featured as a character in a popular Emmy-award-winning streaming series. This development highlights Realbotix's expanding presence across e…

ONCO
Playtika Posts Revenue Beat and Profit Rebound, Shares Tick Up Pre-Market
Aug 6, 2026
Jordan Park
Stock Markets

Playtika Posts Revenue Beat and Profit Rebound, Shares Tick Up Pre-Market

Playtika shares gained modestly in pre-market trading after the mobile gaming company reported Q2 2026 results that beat revenue expectations and showed a significant return to profitability. Revenue of $731.1 million topped the analyst consensus of about $713 million and rose 5.0% year-over-year. Adjusted EBITDA jumped to $206.1 million, while net…

Evolent Health Stock Rockets in Pre-Market After Strong Q2 2026 Results
Aug 6, 2026
Derek Hwang
Stock Markets

Evolent Health Stock Rockets in Pre-Market After Strong Q2 2026 Results

Evolent Health shares jumped 23.4% in pre-open trading after the company reported second-quarter 2026 results that exceeded Wall Street expectations on both earnings and revenue. The report showed EPS of $0.02 versus a consensus -$0.01 and revenue of $652.52 million versus an anticipated $597.46 million, reflecting year-over-year revenue growth nea…

Albemarle Shares Jump After Q2 Results Exceed Estimates
Aug 6, 2026
Marcus Reed
Stock Markets

Albemarle Shares Jump After Q2 Results Exceed Estimates

Albemarle reported second-quarter 2026 results that outpaced analyst expectations, sending the stock higher in pre-market trading. Revenue came in at $1.74 billion and diluted EPS was $3.52, both above consensus ranges. A marked recovery in the Energy Storage segment, led by a near 60.5% rise in realized lithium pricing and double-digit adjusted EB…

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates
Aug 6, 2026
Avery Klein
Press Releases

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

MiNK Therapeutics will report its Q2 2026 financial results and provide clinical updates on its off-the-shelf iNKT cell therapy agenT-797 targeting acute lung injury. The company will discuss new clinical data and the launch of a named-patient program, highlighting progress in treating pulmonary immune failure and other immune disorders.

INKT